Skip to main content
Clinical Trials/NCT02346409
NCT02346409
Completed
Not Applicable

Cerebello-thalamo-cortical Coupling in Essential Tremor: Effects of High Frequency tACS of the Cerebellum

Institut National de la Santé Et de la Recherche Médicale, France1 site in 1 country20 target enrollmentFebruary 4, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Essential Tremor
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrollment
20
Locations
1
Primary Endpoint
The neuronal activity in the cerebello-thalamo-cortical pathway
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

Essential tremor (ET) is a frequent and disabling disorder with progressive worsening of postural tremor of the upper limbs that impairs most of the manual activities of every day life (feeding, drinking, etc.). Although the pathophysiology of essential tremor (ET) is not fully elucidated, tremor is associated with abnormal activity within different brain regions, in particular the thalamus and the cerebellum. Deep brain stimulation (DBS) of the ventral intermediate nucleus of the thalamus (VIM-Thal) reverses the symptoms of tremor but is an invasive procedure. Transcranial stimulation of the cerebellum may represent a non-invasive therapeutic option for ET patients. Here, the investigators propose to test the efficacy of cerebellar stimulation in 15 ET patients previously operated for DBS of the thalamus. To further understand how this treatment provokes tremor reduction, the investigators will analyse the brain neuronal activity in 13 others ET patients candidate to thalamic DBS by using combined electrophysiological recordings of the thalamus (with the electrodes implanted), the cerebellum and the cortex with magnetoencephalography.

Registry
clinicaltrials.gov
Start Date
February 4, 2015
End Date
February 16, 2018
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age below 75 years
  • diagnosis of essential tremor according to the criteria of the Tremor Investigation Group and the Consensus statement of the Movement Disorder Society Group (ref)
  • health insurance
  • signed informed written consent

Exclusion Criteria

  • other neurological disorders
  • medications that interact with or influence brain excitability
  • significant brain lesions detected in MRI

Outcomes

Primary Outcomes

The neuronal activity in the cerebello-thalamo-cortical pathway

Time Frame: 1 day

LFP, MEG and EMG activity recordings

Study Sites (1)

Loading locations...

Similar Trials